In vitro interactions between piperaquine, dihydroartemisinin, and other conventional and novel antimalarial drugs

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 8, 2006, Pages 2883-2885

  Davis, Timothy M E ^a   Hamzah, Juliana ^a   Ilett, Kenneth F ^a   Karunajeewa, Harin A ^a   Reeder, John C ^b   Batty, Kevin T ^c   Hackett, Sara ^a   Barrett, P Hugh R ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^c CURTIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; DIHYDROARTEMISININ; MEFLOQUINE; NAPHTHOQUINONE; PIPERAQUINE; PYRONARIDINE; QUININE;

ANTIMALARIAL ACTIVITY; ARTICLE; CHEMOPROPHYLAXIS; DRUG HALF LIFE; DRUG SENSITIVITY; GROWTH INHIBITION; MALARIA; MOLECULAR CLONING; NONHUMAN; PARASITEMIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT FAILURE;

ANIMALS; ANTIMALARIALS; ARTEMISININS; DRUG COMBINATIONS; DRUG INTERACTIONS; PLASMODIUM FALCIPARUM; QUINOLINES;

EID: 33746891248     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00177-06     Document Type: Article

References (24)

1. Berenbaum, M. C. 1978. A method for testing for synergy with any number of agents. J. Infect. Dis. 137:122-130.
2. Berenbaum, M. C. 1987. Minor synergy and antagonism may be clinically important. J. Antimicrob. Chemother. 19:271-273.
3. Bwijo, B., M. H. Alin, N. Abbas, W. Wernsdorfer, and A. Bjorkman. 1997. Efficacy of artemisinin and mefloquine combinations against Plasmodium falciparum. In vitro simulation of in vivo pharmacokinetics. Trop. Med. Int. Health 2:461-467.
4. Canfield, C. J., M. Pudney, and W. E. Gutteridge. 1995. Interactions of atovaquone with other antimalarial drugs against P. falciparum in vitro. Exp. Parasitol. 80:373-381.
5. Chulay, J. D., J. D. Haynes, and C. L. Diggs. 1983. P. falciparum: assessment of in vitro growth by [3H]-hypoxanthine incorporation. Exp. Parasitol. 55:138-146.
6. Czarniecki, C. W., C. W. Fennie, D. B. Powers, and D. A. Estell. 1984. Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons. J. Virol. 49:490-496.
7. Davis, T. M. E. 2004. Mefloquine, p. 1091-1104. In V. L. Yu, G. Edwards, P. S. McKinnon, C. Peloquin, and G. D. Morse (ed.), Antimicrobial therapy and vaccines, vol. 11. Antimicrobial agents. Apple Trees Productions, New York, N.Y.
8. Davis, T. M. E., T. Y. Hung, I. K. Sim, H. A. Karunajeewa, and K. F. Ilett. 2005. Piperaquine: a resurgent antimalarial drug. Drugs 65:75-87.
9. Davis, T. M. E., H. A. Karunajeewa, and K. F. Ilett. 2005. Artemisinin-based combination therapies for uncomplicated malaria. Med. J. Aust. 182:181-185.
10. Denis, M. B., T. M. E. Davis, S. Hewitt, S. Incardona, K. Nimol, T. Fandeur, Y. Poravutb, C. Lim, and D. Socbeat. 2002. Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria. Clin. Infect. Dis. 35:1469-1476.
11. De Vries, P. J., and T. K. Dien. 1996. Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria. Drugs 52:818-836.
12. Geary, T. G., A. D. Divo, J. B. Jensen, M. Zangwill, and H. Ginsburg. 1990. Kinetic modelling of the response of P. falciparum to chloroquine and its experimental testing in vitro. Implications for mechanism of action of and resistance to the drug. Biochem. Pharmacol. 40:685-691.
13. Gupta, S., M. M. Thapar, S. T. Mariga, W. H. Wernsdorfer, and A. Bjorkman. 2002. Plasmodium falciparum: in vitro interactions of artemisinin with amodiaquine, pyronaridine, and chloroquine. Exp. Parasitol. 100:28-35.
14. Hamzah, J., T. Skinner-Adams, and T. M. E. Davis. 2003. In vitro antimalarial activity of retinoids and the influence of selective retinoic acid receptor antagonists. Acta Trop. 87:345-353.
15. 50 in studies of drug resistance of malaria parasites. Acta Trop. 55:257-261.
16. Jambou, R., E. Legrand, M. Niang, N. Khim, P. Lim, B. Volney, M. T. Ekala, C. Bouchier, P. Esterre, T. Fandeur, and O. Mercereau-Puijalon. 2005. Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet 366:1960-1963.
17. Odds, F. C. 2003. Synergy, antagonism, and what the chequerboard puts between them. J. Antimicrob. Chemother. 52:1.
18. Rahman, N. N. 1997. Evaluation of the sensitivity in vitro of Plasmodium falciparum and in vivo of Plasmodium chabaudi malaria to various drugs and their combinations. Med. J. Malaysia 52:390-398.
19. Rosenblum, M. G. 1991. Biochemical effects of human alpha interferon in combination with alpha-difluromethylornithine on human lymphoblastoid (DAUDI) cells in culture. Lymphokine Cytokine Res. 10:83-87.
20. Skinner-Adams, T., and T. M. E. Davis. 1999. Synergistic in vitro antimalarial activity of omeprazole and quinine. Antimicrob. Agents Chemother. 43:1304-1306.
21. Stabel, E., P. Druilbe, and M. Gentilini. 1988. Antagonism of chloroquine with other antimalarials. Trans. R. Soc. Trop. Med. Hyg. 82:221.
22. Trager, W., and J. B. Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
23. Tran, T. H., C. Dolecek, P. M. Pbam, T. D. Nguyen, T. T. Nguyen, H. T. Le, T. H. Dong, T. T. Tran, K. Stepniewska, N. J. White, and J. Farrar. 2004. Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial. Lancet 363:18-22.
24. World Health Organization. 2001. Antimalarial drug combination therapy. Report of a WHO technical consultation. WHO/CDS/RBM/2001.35. WHO, Geneva, Switzerland.